C.K. Cooper Downgrades Nabi Biopharmaceuticals (NABI) to Hold
Tweet
Share
E-mailGet Alerts NABI Hot Sheet
Price: $1.80 --0%
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Rating Summary:
1 Buy, 0 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 4 | Down: 8 | New: 31
Join SI Premium – FREE
C.K. Cooper downgraded Nabi Biopharmaceuticals (NASDAQ: NABI) from Buy to Hold.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
For more ratings news on Nabi Biopharmaceuticals click here and for the rating history of Nabi Biopharmaceuticals click here.
Shares of Nabi Biopharmaceuticals closed at $5.63 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Wedbush Downgrades Tscan Therapeutics Inc (TCRX) to Neutral
- JPMorgan Downgrades Zhongsheng Group Holdings (881:HK) (ZSHGY) to Neutral
- Berenberg Downgrades Mitie Group PLC (MTO:LN) (MITFY) to Hold
Create E-mail Alert Related Categories
DowngradesRelated Entities
CK CooperSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
